Methylone clinical trials
Methylone is named as an intervention in 3 current clinical trials in our USA register. 2 are recruiting patients now. All registered phases are Phase 3. The lead sponsor is Transcend Therapeutics. The most-studied condition is Post Traumatic Stress Disorder.
How Methylone works
All drug targets →- Post-traumatic stress disorderPhase 2
Mechanisms and diseases from ChEMBL via the Open Targets Platform (release 26.09), ChEMBL record CHEMBL3604010, CC BY-SA 3.0. The Guide to Pharmacology has no record of this medicine, so its targets rest on ChEMBL alone. Trial phases are not approvals: approved uses are shown from the regulators' own records where we hold them.
Patient leaflets for Methylone
The package leaflet is the official guide for patients that comes with every medicine. These links go to the regulators that publish it.
- UKUnited Kingdom: Search MHRA ProductsPatient information leaflets and SmPCs for UK-licensed products.
- USUnited States: Search DailyMedFDA-approved labels, including patient and medication guides.
Leaflets differ between brands and countries; always read the one that comes with your own medicine. This is regulatory information, not medical advice.
Reference identifiers for Methylone
- ChEMBL
- CHEMBL3604010
- DrugBank
- DB19192
- PubChem CID
- 45789647
- CAS number
- 186028-79-5
- FDA UNII
- L4I4B1R01F
- Wikidata
- Q4046265
- Wikipedia
- Methylone
Codes that identify this medicine in other databases, from Wikidata (CC0), matched by its ChEMBL ID. The ATC code is the WHO classification of what the medicine is used for.
Trials by status
Trials by phase
Clinical trials of Methylone
3 trials| Study | Phase | Status | Lead sponsor | Registers |
|---|---|---|---|---|
|
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
NCT07456696 · ClinicalTrials.gov ↗ · Post Traumatic Stress Disorder
|
Phase 3 | Recruiting | Transcend Therapeutics | USA |
|
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD
NCT07836647 · Post Traumatic Stress Disorder
|
Phase 3 | Recruiting | Transcend Therapeutics | USA |
|
An Evaluation of the Long-Term Safety and Efficacy of TSND-201 for the Treatment of PTSD
NCT07670702 · ClinicalTrials.gov ↗ · Post Traumatic Stress Disorder
|
Phase 3 | By invitation | Transcend Therapeutics | USA |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
Conditions studied with Methylone
1 conditionSponsors
lead sponsor per trial| Lead sponsor | Trials |
|---|---|
| Transcend Therapeutics | 3 |
By country register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 3 | 2 |
A trial with sites in more than one country appears in each of those registers.
Related compounds
Questions about Methylone trials
How many clinical trials are testing Methylone?
3 current trials in our USA register name Methylone (also registered as TSND-201) as a drug or biological intervention, as of the registry sync on 10 November 2026. Completed and withdrawn studies are not counted.
Are Methylone trials recruiting patients?
Yes. 2 of the 3 trials are recruiting: 2 with sites in USA. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Who sponsors Methylone clinical trials?
The lead sponsor is Transcend Therapeutics. The number in brackets is how many trials each organisation leads.
Where does this information come from?
Every trial, status, phase and sponsor on this page is copied from public ClinicalTrials.gov records by a daily sync. Nothing here describes how Methylone works or whether it is effective, and it is not medical advice.
How this page is built
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Methylone works or whether it is effective. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, intervention names and synonyms, phase, overall status, lead sponsor and conditions for every trial on this page
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Methylone (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 10 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.